Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 15Terminated 4Withdrawn 2Unknown 2Recruiting 1

Sponsor Class

NIH 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Genitourinary 6Breast 6Other hematologic neoplasm 5Dermatologic 5Lymphoid 3Thoracic 2Sarcoma 2Gynecologic 2Gastrointestinal 2Tumor-Agnostic 1Other solid neoplasm 1Other neoplasm 1Myeloid 1Head & Neck 1

Conditions

Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Small Cell Lung Carcinoma 1

Interventions

Carboplatin 133Cisplatin 130Pemetrexed 114Docetaxel 79Drug Therapy 61Gefitinib 57anlotinib 55Gemcitabine 55Erlotinib Hydrochloride 55Radiotherapy 48Bevacizumab 48pembrolizumab 47Paclitaxel 47Etoposide 44apatinib 42icotinib 41camrelizumab 39osimertinib 35Vinorelbine 31Nivolumab 31Radiosurgery 30sintilimab 29aumolertinib 25endostar protein 24durvalumab 24atezolizumab 23Endostatins 22Blood Specimen Collection 19toripalimab 18Immune Checkpoint Inhibitors 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Gene Expression Profiling × Thoracic × Clear all
NCT00503958 2013-05-15

Liverpool Lung Project: Risk Factors and Genetic Markers in Healthy Participants and Patients With Lung Cancer

National Cancer Institute (NCI)

Unknown
8,300 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Small Cell Lung Carcinoma

NCT00083083 2011-03-01

Fludeoxyglucose F18 Positron Emission Tomography Imaging In Assessing Patients Before and After Treatment for Locally Advanced Non-Small Cell Lung Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
250 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡